Home
Sukumar Nagendran, President and Head of R&D: Taysha Gene Therapies TSHA Sell · Filed 04/13
Trade details
- Type
- Insider sale
- Amount
- $892,000
- Shares · price
- 200,000 sh · $4.46 a share
- Held after
- 1,136,410 sh
- Trade date
- 26/04/10
- Filed
- 26/04/13
- Days to filing
- 3 days
Sold 15.0% of holdings
- Share of holding sold
- 15.0%
Taysha Gene Therapies trades, last 26 weeks
What else happened in Taysha Gene Therapies around then
Filed or reported within 30 days of the trade day · 03/11~05/10Sukumar Nagendran's recent trades
- Sukumar Nagendran
Planned sale10b5-1 planTaysha Gene Therapies
Planned sale10b5-1 planTaysha Gene Therapies
TSHA
$1.3M
200,000 sh
$1.3M
Filed 07/10
Traded 07/10
- Sukumar Nagendran
Planned sale10b5-1 planTaysha Gene Therapies
Planned sale10b5-1 planTaysha Gene Therapies
TSHA
$926K
200,000 sh
$926K
Filed 04/10
Traded 04/10
- Sukumar Nagendran
SellTaysha Gene Therapies
SellTaysha Gene Therapies
TSHA
$423.4K
89,132 sh
$423.4K
Filed 01/27
Traded 01/23
- Sukumar Nagendran
SellTaysha Gene Therapies
SellTaysha Gene Therapies
TSHA
$124.1K
26,918 sh
$124.1K
Filed 01/27
Traded 01/26
- Sukumar Nagendran
Planned saleTaysha Gene Therapies
Planned saleTaysha Gene Therapies
TSHA
$579.4K
113,824 sh
$579.4K
Filed 01/23
Traded 01/23